CERTERA 2026: the new state consortium for advanced therapies and its impact on pharma and biotech
Spain creates CERTERA, a consortium with over 40 institutions to develop gene and cell therapies. Key insights for the p...
6 Articles
Spain creates CERTERA, a consortium with over 40 institutions to develop gene and cell therapies. Key insights for the p...
The EU authorizes the OXTERIL 350 VHP biocide for disinfection. Manufacturers, distributors and professional users must ...
The EU corrects Regulation (EU) 2019/5 on authorization of human and veterinary medicines. Pharmaceutical and veterinary...
The EU includes APIs in the CETA GMP protocol: manufacturer inspections will be mutually recognized between the EU and C...
The CSIC and CESIF agree to jointly develop master's programs, external internships and final projects. The pharmaceutic...
The EU sets its position at the 69th session of the UN Commission on Narcotic Drugs. Pharmaceutical and chemical compani...